Compare GILD & GOOGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series A Mandatory Convertible Preferred Stock
Current Price
| Metric | GILD | GOOGM |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.0B | N/A |
| IPO Year | 2003 | 2015 |
| Metric | GILD | GOOGM |
|---|---|---|
| Price | $148.09 | $48.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $148.39 | N/A |
| AVG Volume (30 Days) | ★ 6.3M | 929.8K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | ★ 1684.21 | 34.45 |
| EPS | N/A | ★ 14.24 |
| Revenue | $24,689,000,000.00 | ★ $402,836,000,000.00 |
| Revenue This Year | $4.68 | N/A |
| Revenue Next Year | $6.04 | N/A |
| P/E Ratio | ★ N/A | $3.46 |
| Revenue Growth | 9.98 | ★ 15.09 |
| 52 Week Low | $108.46 | $46.24 |
| 52 Week High | $157.29 | $53.13 |
| Indicator | GILD | GOOGM |
|---|---|---|
| Relative Strength Index (RSI) | 68.22 | 47.46 |
| Support Level | $142.93 | $48.85 |
| Resistance Level | $149.18 | $52.10 |
| Average True Range (ATR) | 3.35 | 0.62 |
| MACD | 1.09 | -0.05 |
| Stochastic Oscillator | 95.05 | 31.02 |
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV and YouTube Music, among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform accounts for roughly 10% of Alphabet's revenue. The firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.